VRCA

Verrica Pharmaceuticals Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$3.72

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %1 / %30

Non-compliant assets / Total market cap %0 / %30

Non-compliant revenue / Total income %2.8 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts.

Website

Analysis (Turkish): VRCA Hissesi Caiz mi, Helal mi? Verrica Pharmaceuticals Inc. Katılım Analizi